A method for preventing and/or treating drug-induced renal tissue injury and related diseases thereof of a subject, comprising administering an effective amount of plasminogen to a subject. Also provided are a drug, a pharmaceutical composition, a product, and a kit comprising plasminogen and used for preventing and/or treating drug-induced renal tissue injury and related diseases thereof of the subject.